UBS Reiterates Buy Rating on Merck (MRK)

July 10, 2025 8:57 AM UTC Send to a Friend
UBS analyst Trung Huynh reiterated a Buy rating and $105.00 price target on Merck (NYSE: MRK).The analyst commented, "MRK confirmed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login